85 results
8-K
EX-10.1
SLNO
Soleno Therapeutics Inc
30 Jan 24
Departure of Directors or Certain Officers
4:57pm
in the effective control of the Company which occurs on the date that a majority of members of the Board is replaced during any twelve (12) month period … by Directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election
S-3ASR
SLNO
Soleno Therapeutics Inc
2 Jan 24
Automatic shelf registration
4:06pm
by the trustee, the holders of a majority in principal amount of the outstanding debt securities of that series may rescind and annul the acceleration … such duty or exercising such right or power. Subject to certain rights of the trustee, the holders of a majority in principal amount
S-3ASR
EX-4.3
SLNO
Soleno Therapeutics Inc
2 Jan 24
Automatic shelf registration
4:06pm
by the Trustee as hereinafter in this Article provided, the Holders of a majority in principal amount of the outstanding Securities of that Series, by written … with such written request has been given to the Trustee during such 60-day period by the Holders of a majority in principal amount of the outstanding Securities
8-K
EX-10.1
ebwrawj1k s7y
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.2
jprryii12e78foz6m3
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
424B5
ycf50c8h
29 Sep 23
Prospectus supplement for primary offering
4:51pm
424B5
f7v sfakx
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-10.1
e8cizl2shr2mpezjspql
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-10.3
3v7 4gvno
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-10.2
tas8ou37dvv
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K/A
dldiep3dypyx86cuoj
25 Jul 22
Submission of Matters to a Vote of Security Holders
4:05pm